Published in J Clin Microbiol on July 01, 1991
Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis (2013) 4.51
Polymerase chain reaction analysis of aqueous humour samples in necrotising retinitis. Br J Ophthalmol (2003) 1.79
Necrotising retinopathies simulating acute retinal necrosis syndrome. Br J Ophthalmol (2005) 1.22
Utility of a multiplex PCR assay for detecting herpesvirus DNA in clinical samples. J Clin Microbiol (2002) 1.20
Polymerase chain reaction analysis and oligoclonal antibody in the cerebrospinal fluid from 34 patients with varicella-zoster virus infection of the nervous system. J Neurol Neurosurg Psychiatry (2006) 1.18
Detection of multiple viral DNA species in synovial tissue and fluid of patients with early arthritis. Ann Rheum Dis (2000) 1.05
Quantitative real time PCR detection of Varicella-zoster virus DNA in cerebrospinal fluid in patients with neurological disease. Med Microbiol Immunol (2004) 0.95
An immunocompetent patient with a vesicular rash and neurological symptomatology. Case Rep Med (2013) 0.91
Monitoring prevalence of varicella-zoster virus clades in Germany. Med Microbiol Immunol (2010) 0.91
Nested PCR for rapid detection of mumps virus in cerebrospinal fluid from patients with neurological diseases. J Clin Microbiol (2000) 0.90
Varicella zoster virus infection. Nat Rev Dis Prim (2015) 0.90
Deep sequencing to identify the causes of viral encephalitis. PLoS One (2014) 0.87
Role of Mycoplasma pneumoniae in pediatric encephalitis. Eur J Clin Microbiol Infect Dis (2008) 0.87
Central nervous system infection during immunosuppression. Neurol Clin (2002) 0.86
Multiplex detection of human herpesviruses from archival specimens by using matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol (2007) 0.86
Varicella-zoster virus (VZV) glycoprotein E is a serological antigen for detection of intrathecal antibodies to VZV in central nervous system infections, without cross-reaction to herpes simplex virus 1. Clin Vaccine Immunol (2011) 0.83
Cerebrospinal fluid biomarkers in patients with varicella-zoster virus CNS infections. J Neurol (2013) 0.82
Persistent multiple pulmonary nodules in a nonimmunocompromised woman after varicella-related myelitis treated with acyclovir. J Clin Microbiol (2003) 0.81
MENINGOENCEPHALITIS DUE TO VARICELLA ZOSTER VIRUS IN AIDS PATIENTS. REPORT OF ELEVEN CASES AND REVIEW OF THE LITERATURE. Rev Inst Med Trop Sao Paulo (2015) 0.80
Frequent detection of Mycoplasma pneumoniae in Bell's palsy. Eur Arch Otorhinolaryngol (2003) 0.79
Antibodies to varicella zoster virus in the cerebrospinal fluid of neonates with seizures. Arch Dis Child Fetal Neonatal Ed (1998) 0.77
Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science (1988) 220.77
The complete DNA sequence of varicella-zoster virus. J Gen Virol (1986) 16.00
Location and orientation of homologous sequences in the genomes of five herpesviruses. J Gen Virol (1983) 2.29
Antibody assays for varicella-zoster virus: comparison of enzyme immunoassay with neutralization, immune adherence hemagglutination, and complement fixation. J Clin Microbiol (1978) 2.26
False-positive results and the polymerase chain reaction. Lancet (1988) 2.22
Acyclovir therapy for acute herpes zoster. Lancet (1982) 1.95
Genome differences among varicella-zoster virus isolates. J Gen Virol (1983) 1.59
XbaI, PstI, and BglII restriction enzyme maps of the two orientations of the varicella-zoster virus genome. J Virol (1981) 1.58
Herpes zoster-associated encephalitis: clinicopathologic report of 12 cases and review of the literature. Medicine (Baltimore) (1983) 1.50
Establishment of PCR for the early diagnosis of herpes simplex encephalitis. J Med Virol (1990) 1.50
Intrathecal synthesis of IgG antibodies to varicella-zoster virus in two cases of acute aseptic meningitis syndrome with no cutaneous lesions. J Med Virol (1985) 1.07
Analysis of varicella-zoster virus DNAs of clinical isolates by endonuclease HpaI. J Gen Virol (1986) 1.07
Varicella zoster virus transverse myelitis without cutaneous rash. Am J Med (1990) 1.00
Varicella and acute cerebellar ataxia. Arch Neurol (1978) 0.92
The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature (1995) 12.25
Structural changes and functional control of the tick-borne encephalitis virus glycoprotein E by the heterodimeric association with protein prM. Virology (1994) 3.82
Proteolytic activation of tick-borne encephalitis virus by furin. J Virol (1997) 3.78
Oligomeric rearrangement of tick-borne encephalitis virus envelope proteins induced by an acidic pH. J Virol (1995) 3.67
Mutational evidence for an internal fusion peptide in flavivirus envelope protein E. J Virol (2001) 3.58
Cloning and expression of a chitinase gene from the hyperparasitic fungus Aphanocladium album. Curr Genet (1992) 3.24
Molecular organization of a recombinant subviral particle from tick-borne encephalitis virus. Mol Cell (2001) 3.23
Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form. J Virol (1995) 2.97
Mapping of functional elements in the stem-anchor region of tick-borne encephalitis virus envelope protein E. J Virol (1999) 2.87
Recombinant subviral particles from tick-borne encephalitis virus are fusogenic and provide a model system for studying flavivirus envelope glycoprotein functions. J Virol (1996) 2.75
Sequencing the termini of capped viral RNA by 5'-3' ligation and PCR. Biotechniques (1991) 2.64
Antigenic structure of the flavivirus envelope protein E at the molecular level, using tick-borne encephalitis virus as a model. J Virol (1989) 2.59
Sequence of the structural proteins of tick-borne encephalitis virus (western subtype) and comparative analysis with other flaviviruses. Virology (1988) 2.43
Fusion activity of flaviviruses: comparison of mature and immature (prM-containing) tick-borne encephalitis virions. J Gen Virol (1991) 2.34
Structural requirements for low-pH-induced rearrangements in the envelope glycoprotein of tick-borne encephalitis virus. J Virol (1996) 2.33
Tick-borne virus diseases of human interest in Europe. Clin Microbiol Infect (2004) 2.30
Sequence analysis and genetic classification of tick-borne encephalitis viruses from Europe and Asia. J Gen Virol (1999) 2.23
Antibodies induced with recombinant VP1 from human rhinovirus exhibit cross-neutralisation. Eur Respir J (2010) 2.19
The phenomenon of treatment failures in Human African Trypanosomiasis. Trop Med Int Health (2001) 2.18
Spontaneous and engineered deletions in the 3' noncoding region of tick-borne encephalitis virus: construction of highly attenuated mutants of a flavivirus. J Virol (1998) 2.11
Membrane fusion activity of tick-borne encephalitis virus and recombinant subviral particles in a liposomal model system. Virology (2000) 2.09
The flavivirus 3'-noncoding region: extensive size heterogeneity independent of evolutionary relationships among strains of tick-borne encephalitis virus. Virology (1995) 2.08
Adaptation of tick-borne encephalitis virus to BHK-21 cells results in the formation of multiple heparan sulfate binding sites in the envelope protein and attenuation in vivo. J Virol (2001) 1.94
Flat Refractive Geometry. IEEE Trans Pattern Anal Mach Intell (2011) 1.90
Homogeneity of the structural glycoprotein from European isolates of tick-borne encephalitis virus: comparison with other flaviviruses. J Gen Virol (1981) 1.90
The flavivirus envelope protein E: isolation of a soluble form from tick-borne encephalitis virus and its crystallization. J Virol (1991) 1.80
Infectious cDNA clones of tick-borne encephalitis virus European subtype prototypic strain Neudoerfl and high virulence strain Hypr. J Gen Virol (1997) 1.79
Attenuation of tick-borne encephalitis virus by structure-based site-specific mutagenesis of a putative flavivirus receptor binding site. J Virol (2000) 1.77
Genome sequence of tick-borne encephalitis virus (Western subtype) and comparative analysis of nonstructural proteins with other flaviviruses. Virology (1989) 1.76
In vitro-synthesized infectious RNA as an attenuated live vaccine in a flavivirus model. Nat Med (1998) 1.75
Epitope mapping of flavivirus glycoproteins. Adv Virus Res (1986) 1.67
Secondary structure of the 3'-noncoding region of flavivirus genomes: comparative analysis of base pairing probabilities. RNA (1997) 1.62
A model study of the use of monoclonal antibodies in capture enzyme immunoassays for antigen quantification exploiting the epitope map of tick-borne encephalitis virus. J Biol Stand (1986) 1.62
Complete genomic sequence of Powassan virus: evaluation of genetic elements in tick-borne versus mosquito-borne flaviviruses. Virology (1993) 1.54
A topological and functional model of epitopes on the structural glycoprotein of tick-borne encephalitis virus defined by monoclonal antibodies. Virology (1983) 1.53
Establishment of PCR for the early diagnosis of herpes simplex encephalitis. J Med Virol (1990) 1.50
Loss of a histidine residue at the active site of S-locus ribonuclease is associated with self-compatibility in Lycopersicon peruvianum. Proc Natl Acad Sci U S A (1994) 1.46
Characterization of monoclonal antibody-escape mutants of tick-borne encephalitis virus with reduced neuroinvasiveness in mice. J Gen Virol (1997) 1.45
Human milk oligosaccharides are minimally digested in vitro. J Nutr (2000) 1.35
Safety and immunogenicity of an inactivated hepatitis A candidate vaccine in healthy adult volunteers. Vaccine (1990) 1.35
Correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis. J Med Virol (1996) 1.34
Near-patient assays for diagnosis of influenza virus infection in adult patients. Clin Microbiol Infect (2009) 1.32
Viral diagnoses using the rapid immunofluorescence technique and epidemiological implications of acute respiratory infections among children in different European countries. Bull World Health Organ (1984) 1.31
Characterization and complete genome sequences of high- and low- virulence variants of tick-borne encephalitis virus. J Gen Virol (1996) 1.28
Studies with a cold-recombinant A/Victoria/3/75 (H3N2) virus. II. Evaluation in adult volunteers. J Infect Dis (1980) 1.27
Reduced interferon-gamma expression in peripheral blood mononuclear cells of infants with severe respiratory syncytial virus disease. Am J Respir Crit Care Med (1999) 1.26
Recombinant and virion-derived soluble and particulate immunogens for vaccination against tick-borne encephalitis. Vaccine (1995) 1.26
Reconstruction of orbital wall defects: critical review of 72 patients. Int J Oral Maxillofac Surg (2007) 1.24
Antibody-induced conformational changes result in enhanced avidity of antibodies to different antigenic sites on the tick-borne encephalitis virus glycoprotein. Virology (1984) 1.23
Role of metastability and acidic pH in membrane fusion by tick-borne encephalitis virus. J Virol (2001) 1.23
Expression of cloned envelope protein genes from the flavivirus tick-borne encephalitis virus in mammalian cells and random mutagenesis by PCR. Virus Genes (1994) 1.21
The interactions of the flavivirus envelope proteins: implications for virus entry and release. Arch Virol Suppl (1994) 1.20
Chemical crosslinking of tick-borne encephalitis virus and its subunits. J Gen Virol (1980) 1.19
A single amino acid substitution in envelope protein E of tick-borne encephalitis virus leads to attenuation in the mouse model. J Virol (1990) 1.19